What does MARIEC.C-PHARMA do?

MARIEC.C-PHARMA is a pharmacy in Seneffe. Private Limited, started on 22 December 2014, 1 establishment.

What is the address of MARIEC.C-PHARMA?

The registered office of MARIEC.C-PHARMA is located at Rue des Canadiens 24, 7180 Seneffe.

Is MARIEC.C-PHARMA still active?

Yes. According to the CBE (30 October 2026) MARIEC.C-PHARMA is active, legal situation “Normale toestand”, started on 22 December 2014.

Is MARIEC.C-PHARMA registered on Peppol?

Yes, MARIEC.C-PHARMA is registered on the Peppol network with ID 0208:0507640788.

What is the enterprise number of MARIEC.C-PHARMA?

The enterprise number of MARIEC.C-PHARMA is BE0507640788.

When was MARIEC.C-PHARMA founded?

MARIEC.C-PHARMA was founded on 22 December 2014.

Who are the directors of MARIEC.C-PHARMA?

According to the 2025 annual accounts, the directors of MARIEC.C-PHARMA are: DEVANTHINIC PHARMA.

Is MARIEC.C-PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MARIEC.C-PHARMA make in 2025?

MARIEC.C-PHARMA recorded a loss after taxes of € 127,351 in financial year 2025.

What is the revenue of MARIEC.C-PHARMA?

As a small company, MARIEC.C-PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -33,113.

MARIEC.C-PHARMA (Private Limited) - Seneffe

Dossier MARIEC.C-PHARMA, printed on 30 October 2026 from databakkes.be/en/0507640788/mariec-c-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

11 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

MARIEC.C-PHARMA from Seneffe, company number BE0507640788, closed financial year 2025 with a result of € -127,351 after tax. For that financial year MARIEC.C-PHARMA recorded a gross margin of € -33,113 and equity of € 288,410. Compared with financial year 2024, the result moved from € -28,201 to € -127,351. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Healthy

€ 288,410

▼ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -127,351

▼ 352 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 92,373

▼ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 269,860.

Debts at end 2025

Bank debt

€ 450,000

▲ € 430,500 vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 10,851

▼ 90% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,146

▼ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 114,516 Gross margin 2022: € 114,516 First fiscal year in the series	€ 136,942 Gross margin 2023: € 136,942 ▲ 20% vs 2022 (€ 114,516) Favourable step	€ 2,562 Gross margin 2024: € 2,562 ▼ 98% vs 2023 (€ 136,942) Unfavourable step	€ -33,113 Gross margin 2025: € -33,113 ▼ € 35,675 vs 2024 (€ 2,562) Unfavourable step	▼ € 35,675
Profit after taxes	€ 59,197 Profit after taxes 2022: € 59,197 First fiscal year in the series	€ 91,795 Profit after taxes 2023: € 91,795 ▲ 55% vs 2022 (€ 59,197) Favourable step	€ -28,201 Profit after taxes 2024: € -28,201 ▼ € 119,996 vs 2023 (€ 91,795) Unfavourable step	€ -127,351 Profit after taxes 2025: € -127,351 ▼ € 99,150 vs 2024 (€ -28,201) Unfavourable step	▼ € 99,150
Equity	€ 352,167 Equity 2022: € 352,167 First fiscal year in the series	€ 443,962 Equity 2023: € 443,962 ▲ 26% vs 2022 (€ 352,167) Favourable step	€ 415,761 Equity 2024: € 415,761 ▼ 6% vs 2023 (€ 443,962) Unfavourable step	€ 288,410 Equity 2025: € 288,410 ▼ 31% vs 2024 (€ 415,761) Unfavourable step	▼ 31%
Total debts	€ 477,477 Total debts 2022: € 477,477 First fiscal year in the series	€ 37,223 Total debts 2023: € 37,223 ▼ 92% vs 2022 (€ 477,477) Favourable step	€ 138,211 Total debts 2024: € 138,211 ▲ 271% vs 2023 (€ 37,223) Unfavourable step	€ 470,997 Total debts 2025: € 470,997 ▲ 241% vs 2024 (€ 138,211) Unfavourable step	▲ 241%
Cash	€ 543,863 Cash 2022: € 543,863 First fiscal year in the series	€ 341,164 Cash 2023: € 341,164 ▼ 37% vs 2022 (€ 543,863) Unfavourable step	€ 277,591 Cash 2024: € 277,591 ▼ 19% vs 2023 (€ 341,164) Unfavourable step	€ 92,373 Cash 2025: € 92,373 ▼ 67% vs 2024 (€ 277,591) Unfavourable step	▼ 67%
Land & buildings	€ 23,042 Land & buildings 2022: € 23,042 First fiscal year in the series	€ 21,570 Land & buildings 2023: € 21,570 ▼ 6% vs 2022 (€ 23,042) Unchanged	€ 19,741 Land & buildings 2024: € 19,741 ▼ 8% vs 2023 (€ 21,570) Unchanged	€ 510,546 Land & buildings 2025: € 510,546 ▲ € 490,805 vs 2024 (€ 19,741) Unchanged	▲ € 490,805
Retained profit	€ 333,617 Retained profit 2022: € 333,617 First fiscal year in the series	€ 425,412 Retained profit 2023: € 425,412 ▲ 28% vs 2022 (€ 333,617) Favourable step	€ 397,211 Retained profit 2024: € 397,211 ▼ 7% vs 2023 (€ 425,412) Unfavourable step	€ 269,860 Retained profit 2025: € 269,860 ▼ 32% vs 2024 (€ 397,211) Unfavourable step	▼ 32%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 19,500 Bank debt 2024: € 19,500 Unchanged (€ 0) Unfavourable step	€ 450,000 Bank debt 2025: € 450,000 ▲ € 430,500 vs 2024 (€ 19,500) Unfavourable step	▲ € 430,500
Balance sheet total	€ 829,643 Balance sheet total 2022: € 829,643 First fiscal year in the series	€ 481,185 Balance sheet total 2023: € 481,185 ▼ 42% vs 2022 (€ 829,643) Unchanged	€ 553,972 Balance sheet total 2024: € 553,972 ▲ 15% vs 2023 (€ 481,185) Unchanged	€ 759,407 Balance sheet total 2025: € 759,407 ▲ 37% vs 2024 (€ 553,972) Unchanged	▲ 37%

Key figures of MARIEC.C-PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MARIEC.C-PHARMA?

What happened at MARIEC.C-PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: loss of € 127,351. filed late Source: NBB ↗
2024 DEVANTHINIC PHARMA became a director. NBB
Dec 22, 2014 New establishment in La Louvière. KBO
Dec 22, 2014 Start of the company according to the CBE. KBO

In short

From € 59,197 profit in 2022 to € 127,351 loss in 2025.

Paid € 56,840 in corporate taxes since 2022.

Best year ever: 2023, with € 91,795 profit.

Original PDFs at the National Bank ↗

Management

DEVANTHINIC PHARMA 100%

The stake of DEVANTHINIC PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MARIEC.C-PHARMA

Behind MARIEC.C-PHARMA is DEVANTHINIC PHARMA. The shares are held by DEVANTHINIC PHARMA (100%).

Directors

According to the 2025 annual accounts

DEVANTHINIC PHARMA

Director

Also active at: PHARMACIE DE LA DRÊVE, PHARMACIE DE BOIS-D'HAINE, PHARMACIE DE BASCOUP, PHARMACIE SENEFFE CENTRE, Pharmacie LOISEAU, PHARMACIE ANNE ANDRE, PHARMACIE DE LA GRAND RUE, PHARMACIE DE LA VILLE BASSE +2 more

since 2024

Shareholders

DEVANTHINIC PHARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Canadiens 24

7180 Seneffe

2.238.222.144

Boulevard Mairaux(L.L) 19

7100 La Louvière

Active since 22 December 2014

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.

All companies at this address →

PHARMACIE DE LA DRÊVE same network

€ 287,815 gross margin · 2025

PHARMACIE DE BOIS-D'HAINE same network

€ 317,344 gross margin · 2025

PHARMACIE DE BASCOUP same network

€ 517,152 gross margin · 2025

PHARMACIE SENEFFE CENTRE same network

€ 576,922 gross margin · 2025

PHARMACIE ANNE ANDRE same network

€ 357,760 gross margin · 2025

+6 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0507.640.788
VAT number: BE 0507.640.788
Registered office: Rue des Canadiens 24, 7180 Seneffe
Names & denominations: MARIEC.C-PHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 December 2014
Peppol: Active · Active since 29 Dec 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗